EV / EBITDA společnosti Telesis Bio Inc
Jaká je hodnota metriky EV / EBITDA společnosti Telesis Bio Inc?
Hodnota metriky EV / EBITDA společnosti Telesis Bio Inc je N/A
Jaká je definice metriky EV / EBITDA?
EV/EBITDA je podniková hodnota dělená EBITDA (zisk před odečtením úroků, daní, odpisů a amortizací). Měří nákladnost akcie a používá se k porovnání společností mezi sebou častěji než P/E ratio. Měří cenu, jakou investor zaplatí za pohyb hotovosti ve společnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Telesis Bio Inc
Čemu se věnuje společnost Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Firmy s metrikou ev / ebitda podobnou společnosti Telesis Bio Inc
- Hodnota metriky EV / EBITDA společnosti Ximen Mining je N/A
- Hodnota metriky EV / EBITDA společnosti Rebel Capital 2.0 je N/A
- Hodnota metriky EV / EBITDA společnosti Hong Kong Johnson Hldg Co Ltd je N/A
- Hodnota metriky EV / EBITDA společnosti VOTI Detection je N/A
- Hodnota metriky EV / EBITDA společnosti Lift & Co je N/A
- Hodnota metriky EV / EBITDA společnosti Novatti je N/A
- Hodnota metriky EV / EBITDA společnosti Telesis Bio Inc je N/A
- Hodnota metriky EV / EBITDA společnosti In8 Bio je N/A
- Hodnota metriky EV / EBITDA společnosti Nitin Fire Protection Industries je N/A
- Hodnota metriky EV / EBITDA společnosti Renalytix AI plc je N/A
- Hodnota metriky EV / EBITDA společnosti Sunmirror Ag Sf 1 je N/A
- Hodnota metriky EV / EBITDA společnosti Sinotruk (Hong Kong) je N/A
- Hodnota metriky EV / EBITDA společnosti Cross River Ventures je N/A